---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-26-000230"
form_type: "8-K"
ticker: "LEXX"
cik: "0001348362"
company_name: "Lexaria Bioscience Corp."
filed_at: "2026-02-06T23:59:59+00:00"
generated_at: "2026-05-16T04:02:59.071319+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Lexaria Bioscience receives Nasdaq bid price deficiency notice; 180 days to cure

## Summary
- Received Nasdaq deficiency notice on Feb 4, 2026 for failing to meet $1.00 min bid price (Rule 5550(a)(2)).
- Compliance period runs 180 calendar days, until August 3, 2026, to regain compliance.
- To cure, closing bid price must be ≥$1.00 for at least 10 consecutive business days during period.
- If not cured, company may seek second 180-day period if it meets other initial listing standards.
- Failure to regain compliance could lead to delisting; company is evaluating options.

## SEC filing metadata
- accession: 0001640334-26-000230
- form_type: 8-K
- ticker: LEXX
- cik: 0001348362
- company_name: Lexaria Bioscience Corp.
- filed_at: 2026-02-06T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348362/000164033426000230/0001640334-26-000230-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348362/000164033426000230/lxrp_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-26-000230
- JSON: https://secwatch.observer/filing/0001640334-26-000230.json
- Plain text: https://secwatch.observer/filing/0001640334-26-000230.txt

## Source-grounded claims
- claim_id: 9ef70abe50e7421cee1cdcbaeb81371206e9ae25
  claim: Lexaria Bioscience Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  evidence_excerpt: a letter (the “Bid Price Deficiency Notice”) from the listing qualifications department staff of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company is not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the “Bid Price Requirement”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1348362/000164033426000230/0001640334-26-000230-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.